Abstract
The results of the present study of the pharmacokinetics of articaine in children show serum concentrations comparable to those in adults. The maximum values are distinctly lower with the 2% articaine solution. The t max found in our investigation was distinctly earlier than in comparable investigations on adults, whereas the plasma clearance was increased. There is no need to fix a lower mg/kg articaine dose limit for children because of age-related differences in the pharmacokinetics. The use of 2% articaine in pediatric dentistry is particularly advantageous because of the lower C max and the shorter half-life.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Giese R. W. Technical considerations in the use of "high-performance" liquid chromatography in therapeutic drug monitoring. Clin Chem. 1983 Jul;29(7):1331–1343. [PubMed] [Google Scholar]
- Kirch W., Kitteringham N., Lambers G., Hajdu P., Ohnhaus E. E. Die klinische Pharmakokinetik von Articain nach intraoraler und intramuskulärer Applikation. SSO Schweiz Monatsschr Zahnheilkd. 1983 Sep;93(9):714–719. [PubMed] [Google Scholar]
- Müller W. P., Weiser P., Scholler K. L. Pharmakokinetik von Articain bei der Nervus mandibularis-Blockade. Reg Anaesth. 1991 May;14(3):52–55. [PubMed] [Google Scholar]